RIPA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 587
NA - Nord America 490
AS - Asia 253
SA - Sud America 18
AF - Africa 16
OC - Oceania 10
Totale 1.374
Nazione #
US - Stati Uniti d'America 484
SE - Svezia 276
IT - Italia 168
CN - Cina 114
SG - Singapore 90
RU - Federazione Russa 56
FI - Finlandia 22
DE - Germania 21
BR - Brasile 16
GB - Regno Unito 11
AU - Australia 10
IN - India 9
PK - Pakistan 8
NL - Olanda 7
TN - Tunisia 7
FR - Francia 6
KR - Corea 6
IE - Irlanda 5
IR - Iran 5
UA - Ucraina 5
JP - Giappone 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
CA - Canada 3
EG - Egitto 3
HR - Croazia 3
MX - Messico 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AR - Argentina 2
BE - Belgio 2
MA - Marocco 2
MY - Malesia 2
CH - Svizzera 1
DZ - Algeria 1
ES - Italia 1
HK - Hong Kong 1
KZ - Kazakistan 1
MK - Macedonia 1
PL - Polonia 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.374
Città #
New York 70
Lawrence 60
Ashburn 59
Princeton 59
Singapore 57
Shanghai 53
Milan 33
Boardman 32
Moscow 22
Helsinki 21
Rome 15
Seattle 12
Genoa 9
Washington 9
Huskvarna 8
Brisbane 6
Dallas 6
Lahore 6
São Paulo 6
Beijing 5
Guangzhou 5
Padova 5
Pune 5
Turin 5
Vittoria 5
Yongin-si 5
Caruaru 4
Catania 4
Fremont 4
Quezon City 4
Thetford 4
Angera 3
Ballincollig 3
Borås 3
Durban 3
Hanover 3
Los Angeles 3
Lviv 3
Mexico City 3
Wishaw 3
Zagreb 3
Al Qatif 2
Anzio 2
Aversa 2
Bari 2
Basiano 2
Casablanca 2
Casorezzo 2
Dubai 2
Dublin 2
Florence 2
Ghent 2
Houston 2
Hyderabad 2
Maastricht 2
Mahestan 2
Melbourne 2
Naaldwijk 2
Naples 2
Palmas 2
Rio de Janeiro 2
Sacramento 2
Santa Clara 2
Segrate 2
Seremban 2
Shenzhen 2
Stirling 2
Torre Del Greco 2
Varedo 2
Verona 2
Witten 2
Xi'an 2
Zagazig 2
Almaty 1
Amsterdam 1
Andover 1
Bangkok 1
Baoding 1
Beni Khiar 1
Buenos Aires 1
Cairo 1
Carugate 1
Cernusco sul Naviglio 1
Cesano Maderno 1
Chongqing 1
Clifton 1
Cuneo 1
Falkenstein 1
Forlì 1
Frisco 1
Fuzhou 1
Isfahan 1
Izmir 1
Jeddah 1
Jiaxing 1
Kashan 1
Kassel 1
Lainate 1
Lappeenranta 1
Littleton 1
Totale 719
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 80
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 65
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 49
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 41
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 32
Biobanking for COVID-19 research 30
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 29
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
Subclinical myocardial dysfunction in patients recovered from COVID-19 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 27
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 26
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 26
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 26
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 26
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 25
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 24
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 24
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 24
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 24
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 23
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 23
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 23
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 22
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 22
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 22
Ceftobiprole for the treatment of infective endocarditis: A case series 22
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 22
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 21
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 21
Bowel perforation in a Covid-19 patient: case report 21
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 21
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 20
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 20
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 20
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 19
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 19
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 18
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 18
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 18
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 18
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 17
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 17
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 17
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 16
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 15
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 15
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 15
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 14
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 14
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 13
Eosinophils from Physiology to Disease: A Comprehensive Review 13
Rugarli. Medicina interna sistematica 13
Immunosenescence and hurdles in the clinical management of older HIV-patients 12
Rugarli. Medicina interna sistematica 12
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 11
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 11
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 11
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 11
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 10
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 10
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 10
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 10
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 10
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 10
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 10
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 10
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 9
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 9
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 9
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 9
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 6
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 1
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 1
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 1
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 1
Totale 1.519
Categoria #
all - tutte 18.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 0 0 0 0 6 2
2020/202132 1 0 0 5 0 12 1 10 1 0 2 0
2021/2022151 1 0 3 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024519 17 45 92 37 52 111 11 49 5 17 24 59
2024/2025301 116 39 41 71 34 0 0 0 0 0 0 0
Totale 1.519